Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Needham Reiterates Buy on RxSight, Maintains $22 Price Target

Needham Reiterates Buy on RxSight, Maintains $22 Price Target

Needham analyst David Saxon reiterates RxSight (NASDAQ:RXST) with a Buy and maintains $22 price target.

March 7, 2023

1 minute read

Needham analyst David Saxon reiterates RxSight (NASDAQ:RXST) with a Buy and maintains $22 price target.

S&P 500, Nasdaq Close at Record Highs As Wall Street Turns Bullish Amid Improving Investor Sentiment

June 18, 2:30 AM

The CNN Money Fear and Greed index showed an improvement in the overall market sentiment, but the index…

October 7, 9:21 AM

JP Morgan analyst Cory Carpenter maintains IAC (NASDAQ:IAC) with a Overweight and lowers the price target from $95 to $80.

April 16, 4:30 PM

Booking Holdings (NASDAQ:BKNG) has outperformed the market over the past 20 years by 19.93% on an annualized basis…

June 12, 11:57 AM

KeyBanc Capital Markets analyst Jeffrey D.